1291260

CYCLE PHARMACEUTICALS LTD — FEI 3013421522

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 19, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cambridge (United Kingdom)

Additional Details

Postmarket Adverse Drug Experience (PADE)